What is SterRx?
SterRx operates as a FDA registered 503B Outsourcing Facility, distinguished by its expansive 50,000 square foot pharmaceutical building in Plattsburgh, NY. The company's core competency lies in sterile drug manufacture within the contract manufacturing market. Its team comprises seasoned professionals, typically possessing 12 to 15 years of experience in drug manufacturing under stringent cGMP environments, ensuring high standards of quality and compliance.
How much funding has SterRx raised?
SterRx has raised a total of $15M across 1 funding round:
Private Equity
$15M
Private Equity (2017): $15M, investors not publicly disclosed
What's next for SterRx?
The substantial enterprise-level backing positions SterRx for significant expansion and enhanced service offerings. This strategic investment is likely to fuel advancements in manufacturing capabilities, potentially broadening its scope within the contract manufacturing market and solidifying its role as a key player in sterile drug production. The company is poised to leverage this capital for further growth and innovation in meeting the demands of the pharmaceutical industry.
See full SterRx company page
